Search

everythinglearnresearchcommunity

for

Search:↓

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Ulcerative colitis can cause skin issues due to immune system problems.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

DM and AA may share a common cause.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Skin issues can indicate immune system problems.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Upadacitinib improved multiple immune-related conditions in one patient.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.